Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Chest
|
April 6, 2020
Effect of Intermittent or Continuous Feed on Muscle Wasting in Critical Illness: A Phase 2 Clinical Trial
Angela S McNelly, Danielle E Bear, Bronwen A Connolly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 30, 2020
A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit
P Lewis White, Rishi Dhillon, Alan Cordey, et al.
The Lancet. Respiratory Medicine
|
December 19, 2021
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
Benjamin A Fisher, Tonny Veenith, Daniel Slade, et al.
Resuscitation
|
March 25, 2020
Protocol for outcome reporting and follow-up in the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest trial (TTM2)
Gisela Lilja, Niklas Nielsen, Susann Ullén, et al.
American Heart Journal
|
September 2, 2019
Targeted hypothermia versus targeted Normothermia after out-of-hospital cardiac arrest (TTM2): A randomized clinical trial-Rationale and design
Josef Dankiewicz, Tobias Cronberg, Gisela Lilja, et al.
Trials
|
October 8, 2020
Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest: a statistical analysis plan
Janus Christian Jakobsen, Josef Dankiewicz, Theis Lange, et al.
American Heart Journal
|
April 24, 2012
Target Temperature Management after out-of-hospital cardiac arrest--a randomized, parallel-group, assessor-blinded clinical trial--rationale and design
Niklas Nielsen, Jørn Wetterslev, Nawaf al-Subaie, et al.
Intensive Care Medicine
|
April 11, 2018
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
Tobias Welte, R Phillip Dellinger, Henning Ebelt, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Chest
|
April 6, 2020
Effect of Intermittent or Continuous Feed on Muscle Wasting in Critical Illness: A Phase 2 Clinical Trial
Angela S McNelly, Danielle E Bear, Bronwen A Connolly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 30, 2020
A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit
P Lewis White, Rishi Dhillon, Alan Cordey, et al.
The Lancet. Respiratory Medicine
|
December 19, 2021
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
Benjamin A Fisher, Tonny Veenith, Daniel Slade, et al.
Resuscitation
|
March 25, 2020
Protocol for outcome reporting and follow-up in the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest trial (TTM2)
Gisela Lilja, Niklas Nielsen, Susann Ullén, et al.
American Heart Journal
|
September 2, 2019
Targeted hypothermia versus targeted Normothermia after out-of-hospital cardiac arrest (TTM2): A randomized clinical trial-Rationale and design
Josef Dankiewicz, Tobias Cronberg, Gisela Lilja, et al.
Trials
|
October 8, 2020
Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest: a statistical analysis plan
Janus Christian Jakobsen, Josef Dankiewicz, Theis Lange, et al.
American Heart Journal
|
April 24, 2012
Target Temperature Management after out-of-hospital cardiac arrest--a randomized, parallel-group, assessor-blinded clinical trial--rationale and design
Niklas Nielsen, Jørn Wetterslev, Nawaf al-Subaie, et al.
Intensive Care Medicine
|
April 11, 2018
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
Tobias Welte, R Phillip Dellinger, Henning Ebelt, et al.
Page
of 5